<DOC>
	<DOC>NCT00450138</DOC>
	<brief_summary>The purpose of this study is to determine the maximum tolerated dose of ZD6474 given in combination with radiation or in combination with chemotherapy and radiation in patients with squamous cell carcinoma of the head and neck.</brief_summary>
	<brief_title>Open Label, Phase I ZD6474 Head and Neck Cancer Study</brief_title>
	<detailed_description />
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Stage IIIIV squamous cell carcinoma of the head and neck No previous treatment for head and neck cancer, adequate cardiac function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Squamous Cell Carcinoma</keyword>
</DOC>